Literature DB >> 28786532

Blood cell count in antipsychotic-naive patients with non-affective psychosis.

Clemente Garcia-Rizo1,2,3, Marta Casanovas4, Emilio Fernandez-Egea3,5,6, Cristina Oliveira1, Ana Meseguer1, Bibiana Cabrera1,3, Gisela Mezquida1, Miquel Bioque1,3, Brian Kirkpatrick7, Miquel Bernardo1,2,3,8.   

Abstract

BACKGROUND: Schizophrenia is a complex medical entity with a reduced life expectancy, mostly due to an increased prevalence of cardiovascular diseases compared to the general population. An unbalanced immune response and a pro-inflammatory state might underlie this process. In treated patients, abnormal white blood cell (WBC), lymphocyte and neutrophil count suggests atypical immune response related to clinical variables. We aimed to test the hypothesis that newly diagnosed naïve patients with non-affective psychosis would show abnormal blood cell count values after controlling for potential confounding factors compared to matched controls.
METHODS: Seventy-five patients were compared with 80 controls matched for age, gender, body mass index and smoking. Analyses were conducted before and after controlling for smoking.
RESULTS: Patients and controls displayed similar mean values (×103 /μL [SD]) for WBC count 7.02 [2.2] vs 6.50 [1.7] (P = .159), neutrophil count 4.25 [1.8] vs 3.84 [1.3] (P = .110) and monocyte count 0.43 [0.2] vs 0.40 [0.1] (P = .326). After controlling for smoking, 38 non-smoking patients showed a higher WBC and neutrophil count compared with 49 matched controls. Respective means of 7.01 [2.2] vs 5.97 [1.4] (P = .011) for WBC and 4.24 [1.9] vs 3.51 [1.2] (P = .028) for neutrophil count. Monocyte count showed an increased mean value 0.43 [0.2] vs 0.36 [0.1] with a trend towards signification (P = .063).
CONCLUSIONS: These results suggest that abnormal immune response is present before the effects of medication and other confounders had taken place. Increased immune parameters might underlie the high ratio of medical co-morbidities described in schizophrenia.
© 2017 John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  zzm321990WBC count; drug naïve; metabolic disturbances; metabolic syndrome; monocyte count; neutrophil count; non-affective psychosis; schizophrenia

Mesh:

Substances:

Year:  2017        PMID: 28786532     DOI: 10.1111/eip.12456

Source DB:  PubMed          Journal:  Early Interv Psychiatry        ISSN: 1751-7885            Impact factor:   2.732


  8 in total

1.  Monitoring and Treating Metabolic Abnormalities in Patients with Early Psychosis Initiated on Antipsychotic Medications.

Authors:  Kevin M Bozymski; Jessica A Whitten; Mary E Blair; Ashley M Overley; Carol A Ott
Journal:  Community Ment Health J       Date:  2017-11-11

2.  Neutrophil Count Is Associated With Reduced Gray Matter and Enlarged Ventricles in First-Episode Psychosis.

Authors:  Christian Núñez; Christian Stephan-Otto; Judith Usall; Miquel Bioque; Antonio Lobo; Ana González-Pinto; Laura Pina-Camacho; Eduard Vieta; Josefina Castro-Fornieles; Roberto Rodriguez-Jimenez; Anna Butjosa; Joost Janssen; Bibiana Cabrera; Mara Parellada; Miquel Bernardo
Journal:  Schizophr Bull       Date:  2019-06-18       Impact factor: 9.306

3.  DNA methylation meta-analysis reveals cellular alterations in psychosis and markers of treatment-resistant schizophrenia.

Authors:  Eilis Hannon; Emma L Dempster; Georgina Mansell; Joe Burrage; Nick Bass; Marc M Bohlken; Aiden Corvin; Charles J Curtis; David Dempster; Marta Di Forti; Timothy G Dinan; Gary Donohoe; Fiona Gaughran; Michael Gill; Amy Gillespie; Cerisse Gunasinghe; Hilleke E Hulshoff; Christina M Hultman; Viktoria Johansson; René S Kahn; Jaakko Kaprio; Gunter Kenis; Kaarina Kowalec; James MacCabe; Colm McDonald; Andrew McQuillin; Derek W Morris; Kieran C Murphy; Colette J Mustard; Igor Nenadic; Michael C O'Donovan; Diego Quattrone; Alexander L Richards; Bart Pf Rutten; David St Clair; Sebastian Therman; Timothea Toulopoulou; Jim Van Os; John L Waddington; Patrick Sullivan; Evangelos Vassos; Gerome Breen; David Andrew Collier; Robin M Murray; Leonard S Schalkwyk; Jonathan Mill
Journal:  Elife       Date:  2021-02-26       Impact factor: 8.140

Review 4.  Roles of inflammation in intrinsic pathophysiology and antipsychotic drug-induced metabolic disturbances of schizophrenia.

Authors:  Tyler R Prestwood; Roshanak Asgariroozbehani; Sally Wu; Sri Mahavir Agarwal; Ryan W Logan; Jacob S Ballon; Margaret K Hahn; Zachary Freyberg
Journal:  Behav Brain Res       Date:  2021-01-14       Impact factor: 3.332

5.  A Meta-analysis of Immune Parameters, Variability, and Assessment of Modal Distribution in Psychosis and Test of the Immune Subgroup Hypothesis.

Authors:  Toby Pillinger; Emanuele F Osimo; Stefan Brugger; Valeria Mondelli; Robert A McCutcheon; Oliver D Howes
Journal:  Schizophr Bull       Date:  2019-09-11       Impact factor: 9.306

6.  Elevated levels of monocyte-lymphocyte ratio and platelet-lymphocyte ratio in adolescents with non-suicidal self-injury.

Authors:  Qi Zheng; Jin Liu; YaJuan Ji; Yan Zhang; XinChao Chen; BangShan Liu
Journal:  BMC Psychiatry       Date:  2022-09-19       Impact factor: 4.144

7.  Neutrophil-to-Lymphocyte Ratio Is Independently Associated With Severe Psychopathology in Schizophrenia and Is Changed by Antipsychotic Administration: A Large-Scale Cross-Sectional Retrospective Study.

Authors:  Xia Zhou; Xiaolan Wang; Rui Li; Jun Yan; Ying Xiao; Weiguang Li; Hong Shen
Journal:  Front Psychiatry       Date:  2020-10-30       Impact factor: 4.157

8.  Innate Immune Cells and C-Reactive Protein in Acute First-Episode Psychosis and Schizophrenia: Relationship to Psychopathology and Treatment.

Authors:  Johann Steiner; Thomas Frodl; Kolja Schiltz; Henrik Dobrowolny; Roland Jacobs; Brisa S Fernandes; Paul C Guest; Gabriela Meyer-Lotz; Katrin Borucki; Sabine Bahn; Bernhard Bogerts; Peter Falkai; Hans-Gert Bernstein
Journal:  Schizophr Bull       Date:  2020-02-26       Impact factor: 9.306

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.